Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EHRs A Vehicle For Delivering REMS Data To Physicians – FDA’s Woodcock

Executive Summary

PHILADELPHIA – FDA is looking at electronic health records to serve as a vehicle for pushing details of Risk Evaluation and Mitigation Strategies to physicians, FDA Center for Drug Evaluation and Research Director Janet Woodcock said.
Advertisement

Related Content

EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock
Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
Onglyza Data From Sentinel Pilot Can Be Validated By Phase IV Trial, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS053285

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel